BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Gong J, Xu H, Zhang D, Xia N, Li H, Song K, Lv T, Chen Y, Diao Y, Jao J, Dai S, Zhao P, Yao Q. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study. Diagn Cytopathol 2020;48:635-44. [PMID: 32275355 DOI: 10.1002/dc.24427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu T, Chen M, Li X, Wang H. Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67. Int J Gen Med 2022;15:6529-38. [PMID: 35971526 DOI: 10.2147/IJGM.S362685] [Reference Citation Analysis]
2 Hoyer H, Mehlhorn G, Scheungraber C, Hagemann I, Hirchenhain C, Woelber L, Stolte C, Hampl M, Scherbring S, Denecke A, Bartels J, Ebert AD, Meneder S, Petzold A, Heller T, Heidtke KR, Schwarz E, Stübs F, Schütze S, Stange EL, Jaeger A, Martignoni F, Dellmann A, Rody A, Hillemanns P, Fehm T, Petry KU, Böhmer G, Schmalfeldt B, Wimberger P, Beckmann MW, Runnebaum IB, Dürst M. Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance. Cancers (Basel) 2021;13:3309. [PMID: 34282754 DOI: 10.3390/cancers13133309] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Major AL, Skřivánek A, Grandjean EM, Dvořák V, Malík T, Pluta M, Mayboroda I. An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and p16/Ki-67-Associated Abnormal Cytological Cervical Findings: A post-hoc Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and p16 Positive CIN1. Front Med (Lausanne) 2021;8:645559. [PMID: 34113633 DOI: 10.3389/fmed.2021.645559] [Reference Citation Analysis]